Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. (Q51346295)
Jump to navigation
Jump to search
scientific article published on 30 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. |
scientific article published on 30 January 2013 |
Statements
1 reference
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. (English)
1 reference
1 reference
W Y Lee
1 reference
K W Min
1 reference
V K Shivane
1 reference
A R Sosale
1 reference
H C Jang
1 reference
C H Chung
1 reference
I S Nam-Goong
1 reference
J A Kim
1 reference
S W Kim
1 reference
Gemigliptin Study 006 Group
1 reference
30 January 2013
1 reference
15
1 reference
6
1 reference
523-530
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference